NEUROPACE INC. - COMMON STOCK

NeuroPace Provides Update on Tariff Status

14 Apr 2025 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting

08 Apr 2025 08:00:00 By Nasdaq GlobeNewswire

NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting

03 Apr 2025 08:00:02 By Nasdaq GlobeNewswire

NeuroPace Announces Refocusing of Product Portfolio

02 Apr 2025 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference

26 Mar 2025 08:00:01 By Nasdaq GlobeNewswire

NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results

04 Mar 2025 16:05:00 By Nasdaq GlobeNewswire

UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference

03 Mar 2025 21:15:05 By Nasdaq GlobeNewswire

NeuroPace to Present at the Leerink Partners Global Healthcare Conference

03 Mar 2025 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.

20 Feb 2025 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

19 Feb 2025 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

18 Feb 2025 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Announces Pricing of Public Offering of $65 Million of Common Stock

14 Feb 2025 06:33:50 By Nasdaq GlobeNewswire

NeuroPace Announces Proposed Public Offering of $65 Million of Common Stock

13 Feb 2025 16:34:21 By Nasdaq GlobeNewswire

NeuroPace Announces Upcoming Oral Presentation of Data from the Post-Approval Study of the RNS System at the American Academy of Neurology 2025 Annual Meeting Being Held April 5th – 9th

03 Feb 2025 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Issues 2025 Financial Guidance Targets

28 Jan 2025 17:15:59 By Nasdaq GlobeNewswire

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business Updates

08 Jan 2025 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Conference

18 Dec 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Host Investor Day on January 28th in New York City

12 Dec 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting

04 Dec 2024 16:05:00 By Nasdaq GlobeNewswire

NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome

03 Dec 2024 16:05:00 By Nasdaq GlobeNewswire